Novartis Investigative Site

Ajmer, Rajasthan 305001

0 studies enrolling now · 2 studies all time

What they study most

Primary Prevention of Atherosclerotic Cardiovascular Disease, Rheumatoid Arthritis

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents — Completed